Johns Hopkins University-led researchers, working with the Biomarkers for Older Controls at Risk for Dementia (BIOCARD) cohort, have found that certain factors are linked to…
Could we pack the dementia-fighting benefits of exercise into a pill? An intriguing mouse study conducted by USC scientists suggests it may be possible.
Research involving the UAB reveals the most effective way to talk to people with Alzheimer’s so that their emotional response and their levels of attention…
Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital and collaborating institutions discovered that…
A multi-institutional study made up of 26 researchers led by the University of Melbourne has discovered that iron-reducing deferiprone accelerates cognitive decline in patients with…
Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer’s disease or related dementias by mailing patients,…
One of the first studies to investigate the prevalence of unrecognized cognitive impairment among patients seen at Federally Qualified Health Centers, has found that it…
A new therapy may delay Alzheimer’s disease progression by years, according to a study by researchers at Texas A&M University College of Medicine. Published in…
Attempts to discover a breakthrough dementia drug might be drawing attention these days, but traditional medicinal products can offer hints for preventive medicine.
Diagnosis of Alzheimer’s disease (AD) is currently largely based on the presence of biomarkers. This may lead to a problematic over-diagnosis if this is incorrectly…